Diabetes Dialogue: FLOW Trial and Semaglutide's Benefit in Chronic Kidney Disease
May 25th 2024Hosts break down the FLOW trial, take a deep dive into secondary findings, and provide insight into how this alters the perception of the role for semaglutide in management of CKD in type 2 diabetes.
Read More
Diabetes Dialogue: What to Know about Sequel Med Tech's twiist AID System, with Alan Lotvin, MD
March 30th 2024In this episode, Alan Lotvin, MD, of Sequel Med Tech, joins hosts for a deep dive into the twiist automated insulin delivery system, which received clearance for people with T1D in March 2024.
Read More
Diabetes Dialogue: All Things AID at ATTD 2024
March 28th 2024In this episode, all things AID from the 17th annual ATTD, including updates from Insulet Corporation and Omnipod, study data from the Control IQ algorithm, the SMASH study, and a peak into the future with the Neural Network AID algorithm.
Read More
Diabetes Dialogue: Tirzepatide and the Future of Incretin Therapies, with Timothy Garvey, MD
March 4th 2024In this episode, hosts are joined by SURMOUNT-2 principal investigator Timothy Garvey, MD, to discuss the approval of the tirzepatide for chronic weight management, data from the SURMOUNT-2, -3, and 4 programs, the future of incretin therapies, and more.
Read More
Diabetes Dialogue: Time in Range, CGM Metrics for Predicting Outcomes in Diabetes
February 20th 2024Viral Shah, MD, joins Diabetes Dialogue to discuss a recent study examining associations between time in range and other advanced CGM metrics with diabetic retinopathy and the implications for use in predicting other microvascular outcomes.
Read More
Diabetes Dialogue: Updates in Management of Hypercortisolism in Type 2 Diabetes
January 9th 2024In this episode, hosts sit down with Ralph DeFronzo, MD, for a discussion on how advances in management have transformed the diagnosis and management of hypercortisolism among people with type 2 diabetes.
Read More
Diabetes Dialogue: Baricitinib & the Potential Disease-Modifying Therapies in Type 1 Diabetes
January 2nd 2024Hosts discuss a recent study on baricitinib in type 1 diabetes, how these results compare to other data in this arena, and what all of these studies mean for future of type 1 diabetes management.
Read More